Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM
NCT ID: NCT03661203
Last Updated: 2020-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1190 participants
OBSERVATIONAL
2020-09-30
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is divided in two parts. The first one will consist of individual and groups interviews. Then, depending on the items that will rise from the first part of the study, groups interview will take place based on theses items. Finally, a questionnaire build from the collected information will be sent to MSM community in order to obtain quantitative results.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EASY-TESTS: Evaluation of the Acceptability of Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) Who Accepted Targeted HIV/STI Testing, Recruited Through a Community-based Outreach Approach, Both Digital and In-person.
NCT05949814
Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV
NCT01279005
Optimizing PrEP Adherence for Young Men Who Have Sex With Men
NCT03493555
Factors Affecting the Intention to Take nPEP Among Thai MSM
NCT02107911
Residual Risk Assessment Of HIV Transmission
NCT01413152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to uncover the reasons behind the late recourse to HIV testing in MSM population facing a high risk of contamination.
The study hypothesis, is that late recourse to HIV testing is probably related to social and economics factors like age, social standing, accessibility to the diagnosis or even to a traditional beliefs or a fear of stigma etc. To shed the light on these factors, the main objectives of the investigator will try to investigate and analyze the psycho-social hindrances and levers through a quantitative and qualitative approach. This plurality of approaches is a part of a methodological triangulation method described by Kalampalikis \& Apostolidis, 2016.
People among MSM community having had a late or very late HIV test (as defined by biological parameters :CD4≤200/mm3 or having been diagnosed with AIDS), will be recruited in this study. During the first phase of the study, the eligible population will participate to individual or group interview . This qualitative part of the project will allow the set up of a questionnaire that will be diffused widely to the MSM community to have quantitative results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Qualitative cohort
The cohort consists of MSM with late HIV diagnosis. The person from this cohort will participate to round table called also focus group or individual interview.
Focus group
Focus group for qualitative group only
Individual interview
Individual interview for qualitative group only
self questionnaire
online self questionnaire following focus group or individual interview For qualitative group only
Quantitative cohort
MSM community will be invited to participate to an online self questionnaire established from the information gathered from the previous cohort.
online self questionnaire
online self questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus group
Focus group for qualitative group only
Individual interview
Individual interview for qualitative group only
online self questionnaire
online self questionnaire
self questionnaire
online self questionnaire following focus group or individual interview For qualitative group only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported homo-or bisexual contamination mode
* TCD4 + / mm3 200 200 lymphocyte count or Have an AIDS classifying event
* Diagnosis of HIV positive for at least two months and for a maximum of 24 months
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lyon
OTHER
French National Agency for Research on AIDS and Viral Hepatitis
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie Préau, PR
Role: PRINCIPAL_INVESTIGATOR
Université Lumière Lyon 2
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Le 190
Paris, , France
Hopital Saint-Antoine
Paris, , France
Hôpital Pitié-Salpêtrière
Paris, , France
Hôpital Bichat Claude-Bernard
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Mabire-Yon R, Di Ciaccio M, Picard H, Palich R, Supervie V, Preau M. Psychosocial factors involved in the very infrequent use of HIV testing among French MSM: a cross-sectional study. Int J STD AIDS. 2023 Aug;34(9):603-607. doi: 10.1177/09564624231155762. Epub 2023 Feb 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00825-50
Identifier Type: OTHER
Identifier Source: secondary_id
ANRS ReTarD VIH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.